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Background: Following the association of Cronobacter spp. to several publicized fatal outbreaks in neonatal
intensive care units of meningitis and necrotising enterocolitis, the World Health Organization (WHO) in 2004
requested the establishment of a molecular typing scheme to enable the international control of the organism. This
paper presents the application of Next Generation Sequencing (NGS) to Cronobacter which has led to the
establishment of the Cronobacter PubMLST genome and sequence definition database (http://pubmlst.org/
cronobacter/) containing over 1000 isolates with metadata along with the recognition of specific clonal lineages
linked to neonatal meningitis and adult infections
Results: Whole genome sequencing and multilocus sequence typing (MLST) has supports the formal recognition of the
genus Cronobacter composed of seven species to replace the former single species Enterobacter sakazakii. Applying the
7-loci MLST scheme to 1007 strains revealed 298 definable sequence types, yet only C. sakazakii clonal complex 4 (CC4)
was principally associated with neonatal meningitis. This clonal lineage has been confirmed using ribosomal-MLST
(51-loci) and whole genome-MLST (1865 loci) to analyse 107 whole genomes via the Cronobacter PubMLST database. This
database has enabled the retrospective analysis of historic cases and outbreaks following re-identification of those strains.
Conclusions: The Cronobacter PubMLST database offers a central, open access, reliable sequence-based repository for
researchers. It has the capacity to create new analysis schemes ‘on the fly’, and to integrate metadata (source, geographic
distribution, clinical presentation). It is also expandable and adaptable to changes in taxonomy, and able to support the
development of reliable detection methods of use to industry and regulatory authorities. Therefore it meets the WHO
(2004) request for the establishment of a typing scheme for this emergent bacterial pathogen. Whole genome
sequencing has additionally shown a range of potential virulence and environmental fitness traits which may account
for the association of C. sakazakii CC4 pathogenicity, and propensity for neonatal CNS.
Keywords: Emergent bacterial pathogen, Cronobacter, MLST, Genomic analysisBackground
Next generation sequencing and multi-allelic profiling of
emergent bacterial pathogens
Sequence-based methods for bacterial identification started
with single locus sequencing, such as the 16S rRNA gene.
This can differentiate isolates between phylum to genus
level and often to species level, but no further [1]. The ap-
plication of multilocus sequence typing (MLST), typically 7
loci, enables the recognition of bacterial sequence types* Correspondence: Stephen.forsythe@ntu.ac.uk
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unless otherwise stated.(STs) and clonal complexes (CCs). These loci were initially
sequenced individually with specifically designed primers.
Nowadays, the application of Next Generation Sequencing
(NGS) has facilitated whole genome sequencing for the
equivalent cost of 7-loci and therefore has greatly increased
the number of loci that can be used for strain discri-
mination and definition. The use of ribosomal MLST
(rMLST) with 53 loci defined has already been used to de-
fine established bacterial pathogens to the strain level [2].
The use of whole genome MLST (>500 loci) to clone level
is now possible and has been applied in epidemiological
studies for pathogen typing, e.g. Neisseria meningitidis,l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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population genomics of Campylobacter [3-6].
The emergent bacterial pathogen Cronobacter and the
FAO-WHO call for molecular typing methods
Bacteria causing neonatal infections naturally attract at-
tention and invoke a sense of injustice. Following the
recognition of E. sakazakii (former name of Cronobacter
genus) as the causative agent of fatal infections of neo-
nates due to contaminated reconstituted infant formula
[7-9] there were three FAO-WHO risk assessment expert
group meetings [10-12] on the microbiological safety of
these products on the international market. This was the
first occasion that the WHO had aimed to control a food-
borne bacterial pathogen. However at that time there had
been few studies of relevance to help with imposing in-
ternational control measures. Also the organism had
undergone a number of taxonomic evaluations based on
phenotypic tests resulting in confusing and conflicting in-
formation hampering the international control of this
emergent bacterial pathogen by the development of specifc
detection methods. Isolates had been variously described
as Praschechia flavescens and ‘yellow-pigmented Entero-
bacter cloacae’, before a key study renaming them as E.
sakazakii in 1980 and dividing the species into 15 biotypes
[13]. Subsequently in order to reduce the risk of further
neonatal infections, the FAO-WHO executive encouraged
the setting up of appropriate detection and molecular typ-
ing schemes [10]. These are required for the adequate
monitoring of sources and vehicles of the bacterium, in
order to reduce the risk of neonatal exposure. These key
points from the FAO-WHO executive summary are repro-
duced in Additional file 1: Box 1.
To date NGS of bacteria has primarily focused on well
described organisms of clinical relevance such as Escher-
ichia coli and Salmonella. This article, instead, considers
the application of NGS to the newly emergent bacterial
pathogen Cronobacter which was totally unlike Salmon-
ella or E. coli with the lack of former information on
its habitats, diversity, physiological or virulence traits
The three tasks set by the FAO-WHO expert group
(Additional file 1: Box 1) form the basis for this article
to illustrate how using NGS has led to the establishment
of the Cronobacter PubMLST genome database, and en-
abled the improved understanding and control for this
emergent bacterial pathogen of international importance.
Each task will be covered below as a discourse.
Results and discussion
Multilocus sequence typing of Cronobacter spp. and the
Cronobacter PubMLST database
The need for an internationally validated detection and
molecular typing method for the genus Cronobacter is
needed given the severe outcomes of infections in neonatesand the attributed link to contaminated powdered infant
formula on the international market [10-12]. The Crono-
bacter PubMLST database includes the MLST profiling of
isolates from all reported outbreaks around the world. Since
the database also contains the metadata for over 1000
isolates an informed understanding of the diversity and
sources of the organism can now be obtained. The
MLST scheme covers all recognised species of Crono-
bacter genus, to better quantitate the intraspecific and
interspecific diversity of the genus as well as potentially
characterize the strains according to virulence groupings
and source. It also enables the retrospective analysis of
historic cases and outbreaks following re-identification of
those strains which otherwise would have been lost due to
taxonomic re-evaluations.
The organism initially was only known as a single spe-
cies, Enterobacter sakazakii, composed of various bio-
types based on phenotyping [13]. The application of 16S
rRNA and dnaG gene sequencing led to the initial rec-
ognition that the organism was in fact composed of
several species, and formed a unique genus that was
distinguishable from Enterobacter [14]. The new genus
was named Cronobacter to reflect the association of
the bacterium with infant death (Kronos – Greek
mythological god) [15].
However 16S rRNA gene sequencing was unable to
distinguish between all Cronobacter species and biotyping
based on phenotypic tests gave subjective results. In order
to overcome various limitations of phenotyping and 16S
rDNA sequence analysis, the Cronobacter seven-loci
MLST scheme was developed [16,17]. The Cronobacter
MLST scheme requires the partial sequence analysis of
seven housekeeping genes: ATP synthase b chain (atpD),
elongation factor G (fusA), glutaminyl tRNA synthetase
(glnS), glutamate synthase large subunit (gltB), DNA
gyrase subunit B (gyrB), translation initiation factor IF-2
(infB) and phosphoenolpyruvate synthase A (ppsA).
When concatenated together these sequences provide
3036 nucleotides; the analysis of which is termed multilo-
cus sequence analysis (MLSA). A MLSA phylogenetic tree
of the Cronobacter genus and the closely related genera
Franconibacter and Siccibacter is shown in Figure 1. A
current description of the Cronobacter genus is given in
Additional file 1: Box 2.
Before 2004 the number of Enterobacteriaceae (except
for Salmonella) permitted in powdered infant formula
was <100 cfu/g. These specifications had not been re-
vised since 1979. However following the concern of the
serious implications following Cronobacter infections of
neonates, the microbiological criteria changed such that
any member of the Cronobacter genus should not be de-
tectable in 10 g test volume quantities of powdered in-
fant formula [18]. Reliable detection of Cronobacter spp.
has also been problematic due to the genus being poorly
Figure 1 Maximum likelihood tree of the seven multilocus sequence typing loci (3036 base pair concatenated length) for the members
of Cronobacter genus and closely related Franconibacter and Siccibacter genera. The tree was drawn using MEGA 6.05 (http://www.
megasoftware.net/) with 1000 bootstrap replicates.
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the general Enterobacteriaceae differential agar VRBGA,
and then identified using a non-specific commercial
phenotyping test kit resulting in considerable opportu-
nity for false negative results [19]. While much of this
topic is outside the scope of this article, it is pertinent to
note that one biochemical trait that has predominated in
the development of specific chromogenic agar is the con-
stitutive expression of a maltose uptake mechanism and α
–glucosidase [20]. This will be reconsidered in the last
section with respect to taxonomy of the genus.
Sources and vehicles of Cronobacter spp.
Investigating 1007 isolate entries in the Cronobacter
MLST database reveals for the first time the temporal,
geographic and source diversity of the organism; Table 1.
The earliest isolate (C. sakazakii NCIMB 8282) was from
dried milk powder in 1950; the genome of which has
now been published and is one of 107 genomes which
can now be analysed via the PubMLST database [21].Table 1 Summary of Cronobacter isolates in the Cronobacter P
Species Number of
strains (%)
Number
of STsa
Number
of genomes
Earliest
isolate
Co
C. sakazakii 726 (72.1) 155 73 1950
C. malonaticus 136 (13.5) 53 14 1973
C. dublinensis 59 (5.9) 44 9 1956
C. turicensis 41 (4.1) 26 6 1970
C. muytjensii 35 (3.5) 14 2 1988
C. universalis 9 (0.9) 5 2 1956
C. condimenti 1 (0.1) 1 1 2010
Total 1007 298 107
aSequence type.
bPercentage of species total.
cPercentage of genus total.Cronobacter strains have been isolated from 36 countries,
and are from clinical (20.4%), infant formula (21.6%), food
and food ingredients (14.2%), environmental (35.15%)
and other sources such as water (4%); Tables 1 and 2.
Cronobacter spp. isolation from plant material (wheat,
rice, herbs, and spices) and various food products has
previously been reported [22]. However, due to the his-
tory of concern, it is not surprising that a large portion
of strains in the database are clinical or from powdered
infant formula in origin.
The index of association (IA) is a measure of the link-
age of a population. The IA values for the genus Crono-
bacter was found to be significantly greater than zero
(p < 0.001), indicating the presence of linkage disequilib-
rium or clonality [16,17]. Clonal complexes are the STs
which share 3 or more loci to the central ST. This
recognises there are variants of each allele, for example
single and double locus variant (SLV, DLV). A number
of these large clonal complexes are especially significant
with respect to strain clustering according to theirubMLST database
untries Source
Clinical Infant
formula
Food and
ingredients
Environment Other
33 19.8b 23.8 32.8 16.3 7.3
17 36.0 16.2 36.8 7.4 3.7
11 5.1 13.6 47.5 6.8 27.1
12 17.1 12.2 36.6 22.0 12.2
10 2.9 28.6 45.7 2.9 20.0
6 11.1 0.0 55.6 11.1 22.2
1 0 0 100 0 0
36 20.4c 21.6 14.2 35.1 8.7
Table 2 Profile of the source for the major sequence types in C. sakazakii and C. malonaticus
Cronobacter
species
Clonal
group
Number of
profiled
isolates
Percentage
of species
isolates
Infant (<1 y)b Child
(>1 y)
Adult
(>18 y)
Unknowne Source
Uncertainc Meningitis NECd Septicaemia Clinical
total
Infant
formula
Food &
ingredients
Environment Others
C. sakazakii (726)a CC4 195 26.9 4.6 10.0 5.1 4.1 2.1 16.9 2.0 45.1 24.6 8.2 16.9 5.6
CC1 80 11.0 2.5 3.8 0.0 1.3 1.3 0.0 3.8 12.5 30.0 22.5 31.3 3.8
CC8 35 4.8 5.7 0.0 0.0 0.0 5.7 0.0 20.0 31.4 17.1 37.1 5.7 8.6
CC64 28 3.9 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.6 46.4 35.7 7.1 7.1
CC45 25 3.4 0.0 0.0 0.0 0.0 0.0 0.0 4.0 4.0 8.0 52.0 32.0 4.0
CC13 24 3.3 10.5 0.0 0.0 0.0 0.0 0.0 0.0 8.3 29.2 58.3 0.0 4.2
CC3 19 2.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 10.5 31.6 36.8 15.8 5.3
ST12 15 2.1 27.3 0.0 13.3 0.0 0.0 0.0 26.7 60.0 20.0 20.0 0.0 0.0
CC83 11 1.5 0.0 0.0 0.0 9.1 0.0 0.0 0.0 9.1 18.2 9.1 63.6 0.0
C. malonaticus (136) CC7 58 42.6 3.4 0.0 0.0 0.0 22.4 15.5 15.5 56.9 12.1 25.9 0.0 5.2
aNumber of strains for each species in PubMLST database. See Table 1.
bPercentage of strains in each clonal group.
cNo clinical presentation for infant isolate known.
dNecrotizing enterocolitis.
eClinical, unknown presentation and host information.
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section.
The majority of Cronobacter infections, albeit less se-
vere, are in the adult population [12]. An age profile of
Cronobacter isolated using throat swabs from over
45,000 outpatients during the period 2005–2011 has
been published [23]. The organism was isolated from
every age group with a higher frequency from children
less than 14 years of age. However the speciation and se-
quence type of these clinical isolates has not been pub-
lished. As neonates are frequently fed reconstituted
powdered infant formula (PIF), which is not a sterile
product, this potential vector has been the focus of at-
tention for reducing infection risk to neonates as the
number of exposure routes is limited. It should be noted,
however, that not all have been associated with reconsti-
tuted formula ingestion, and the organism has been iso-
lated from the feeding tubes of neonates not receiving
reconstituted powdered infant formula [24].
GoeBURST analysis shows the formation of clonal
complexes among the 298 identified STs for the Crono-
bacter genus (Figure 2), and an uneven distribution of
clinical isolates across both the species and sequence
types [17,25,26]. Some of these large clonal complexes
are especially significant with respect to strain clustering
according to their isolation sources. All sequence typesFigure 2 Population snapshot of the Cronobacter MLST database gen
complexes and the diversity of the sources of the strains. The thresho
are represented by the circles with larger diameters. From Joseph & Forsythcan be analysed from the open access database which is
updated regularly, however for convenience only se-
lected ones are considered in detail below.
Clonal complex 4 (CC4) comprises single and double
loci variants of C. sakazakii ST4. Currently these strains
comprise 19.4% (n = 195) of the Cronobacter genus data-
base. Forty-five percent (88/195) of these are clinical iso-
lates and 24.6% (48/195) have been isolated from
powdered infant formula; Table 2. This analysis demon-
strates the importance of this clonal lineage with respect
to Cronobacter spp. epidemiology as CC4 has been identi-
fied as a genetic signature for the C. sakazakii meningitic
pathovar. Previously Joseph and Forsythe announced the
strong association between neonatal meningitis cases and
C. sakazakii ST4 using a retrospective study of only 41
clinical strains from 1953 to 2008, collected from 7 coun-
tries [27]. This association was confirmed by the analysis
of 15 USA cases in 2011 [26]. These two earlier predic-
tions of the association of C. sakazakii CC4 with menin-
gitis are confirmed in Table 2 where, from over a
hundred clinical isolates, this clonal lineage is prevalent
and is recovered more frequently than other sequence
types from infant infections especially cases of meningi-
tis (20/23 cases). The reason for the association of one
clonal complex in the genus with neonatal meningitis is
unclear at present as no particular virulence traits haveerated using the GoeBURST algorithm, indicating the clonal
ld for the output was set to triple locus variation. The dominant STs
e, 2012.
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other sequence types [17].
It is notable that 24.6% (n = 195) of C. sakazakii CC4
isolates were from infant formula and also that 16.9% of
isolates were from environmental sources such as milk
powder and infant formula manufacturing plants; Table 2.
This supports the previous individual reports of isolates
from in Ireland and Switzerland [28,29]. Sonbol et al. [30]
reported that C. sakazakii CC4 accounted for 25% of
Cronobacter strains isolated from the environment of 6
milk powder manufacturing plants in Australia and
Germany, as well re-identified strains from an inter-
national survey in 1988 of Cronobacter in PIF. The fin-
ished genome sequence of a C. sakazakii CC4 strain
(SP291) has been published, and was notable for its per-
sistence in a PIF production facility in Ireland [29].
They also identified stress response and antimicrobial
resistance genes in the genome. Furthermore, Muller
et al. [28] used pulsed-field gel electrophoresis to match
environmental isolates of C. sakazakii CC4 in a PIF
manufacturing plant in Switzerland with those in the
finished product. Therefore C. sakazakii CC4 may repre-
sent a particularly persistent clonal variant resulting in
increased neonatal exposure. Whether the association of
C. sakazakii CC4 with neonatal meningitis is due to
greater neonatal exposure as a result of environmental
fitness (i.e. desiccation persistence) or particular viru-
lence capabilities is uncertain [17,27]. Therefore an im-
proved understanding of C. sakazakii CC4 strains is
warranted to understand its prevalence both in PIF
manufacturing plants and severe neonatal infections.
New genomic profiling of C. sakazakii CC4 strains is
presented in the last section.
C. sakazakii clonal complex 1 (CC1) is the next prom-
inent ST consisting of 80 strains (11% of C. sakazakii
strains in the database) isolated from around the world
over a period of more than 25 years; Tables 1 and 2.
These have been isolated from PIF and from milk pow-
der processing factories [28,30]. There are proportion-
ately fewer (12.5%) CC1 clinical isolates compared to
CC4 (45.1%), and only three (3.8%) of these strains are
associated with meningitis [10]; Table 2. C. sakazakii
CC1 strains were isolated from infant formula in 1994
used during a neonatal intensive care unit Cronobacter
spp. outbreak in France [31]. Those strains did not
match isolates from the infected neonates according to
pulsed-field gel electrophoresis, and which were later
shown to be C. sakazakii CC4 Also linked to this clonal
complex is ST57 (DLV to ST1), which is the profile of a
PIF isolate from Denmark in 1988. There are no known
isolates of CC1 from adult patients which may indicate
an adaptation to host by other clonal lineages.
Forty percent of C. malonaticus strains (n = 136) re-
corded in the database are in clonal complex 7. Strainsin this complex have been isolated over the past 30 years.
Within this complex 57% (33/58) of strains are clinical in
origin and primarily from children and adults; Table 2. Only
one reported fatal neonatal meningitis case has been attrib-
uted to C. malonaticus, though the vehicle of infection is
uncertain and not necessarily linked to the consumption of
infant formula [26]. The database only contains seven C.
malonaticus CC7 isolates from PIF indicating a low inci-
dence of this complex, and there are no isolates from infant
formula or milk powder manufacturing plants.
Table 2 also shows for the first time that C. sakazakii
ST12 has been associated with cases of necrotizing entero-
colitis (13% of strains) and not neonatal meningitis or
septicaemia. Although there are isolates in the database
from infant formula, unlike CC4 there have been none
from milk powder or infant formula manufacturing plants.
The remaining clonal groups in Table 2 are less clinically
relevant, and are more food and environmental isolates.
The online Cronobacter MLST database has therefore
enabled the open recording of sources of Cronobacter
isolates and can be interrogated by researchers, industry
and regulatory authorities. The recording of the isolates
is standardized and therefore facilitates an international
contribution to collating information.
Ecology of Cronobacter spp.
Table 2 shows all seven Cronobacter species have been iso-
lated from food and food ingredients and these comprise
14.2% of the total profiled isolates. These are primarily
from plant material including herbs and spices [22,32].
This is reflected in common physiological features which
have been found in the genome [32-34]: yellow pigmenta-
tion for oxygen radical protection, capsule formation (ad-
herence to plant surfaces) and efflux pumps (resistance to
essential oils). Since plants are common food ingredients,
these Cronobacter strains have been isolated from salads,
cake mixes, packet soup, flavoured teas as well as pow-
dered infant formula and weaning foods [35]. Table 2
shows that C. sakazakii CC4 strains are not so frequently
isolated from food and food ingredients as C. malonaticus
CC7; 8.2% compared to 25.9% of isolates. This may reflect
the ecological diversity of the various clonal types and
adaptation to niche. Another source for Cronobacter
given in the database is water where 14/38 strains are C.
dublinensis, and 13/38 are C. sakazakii, with no C.
sakazakii ST4 strains. Despite one reported serious infec-
tion which can be attributed to reconsititution with water
containing Cronobacter, prior to this analysis, water as a
source of the bacterium has not received much atten-
tion [26].
Taxonomy of the Cronobacter genus
Control of the organism requires a clear definition of the
organism to distinguish it from closely related organisms
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is therefore essential for regulatory control because the de-
tection methods must be based on a thorough under-
standing of the diversity of the target organism. A number
of early Cronobacter detection methods were based on
small numbers of poorly characterized, even misidentified,
strains and therefore are not necessarily reliable for their
stated purpose.
The application of NGS enabled an improved under-
standing of the taxonomy of the Cronobacter genus. The
Cronobacter genus belongs to the bacterial class gamma-
proteobacteria, and is within the family Enterobacteriaceae
with the nearest relatives being the newly described genus
Kosakonia as well as the more familiar genera Citrobacter
and Pantoea. Members of the latter include Citrobacter
koseri which is notable as it is associated with invasive
neonatal meningitis with clinical presentations of brain
abscess formation. These symptoms are similar to those of
Cronobacter spp. meningitis, and differ from those of the
neonatal meningitis pathovar E. coli K1. Also members of
the Pantoea spp. are primarily plant-borne and frequently
are yellow pigmented as per the majority of Cronobacter
isolates. Enterobacter hormaechei and E. ludwiggii isolates
have been misidentified as Cronobacter which has led to
some confusion in the literature [32].
Before the first (2004) FAO-WHO expert meeting
yellow-pigmented Enterobacter cloacae-like bacterial strains
were called Enterobacter sakazakii. Following further ana-
lysis, the Cronobacter genus was initially proposed for all
previous E. sakazakii strains. The Cronobacter species
were differentiated by Iversen et al. [15] according to 16 E.
sakazakii biotypes; C. sakazakii (biotypes 1–5, 7, 8, 9, 11,
13 and 14), C. turicensis (biotypes 16, 16a and 16b), C.
muytjensii (biotype 15), and C. dublinensis (biotypes 6, 10
and 12). This was quickly revised [36] with the addition of
C. malonaticus (biotypes 5, 9 and 14). This latter species
had originally been described as a sub-species of C.
sakazakii by Iversen et al. [15] who could not distin-
guish C. sakazakii and C. malonaticus using 16S rDNA
sequence analysis. Distinguishing between the two species
had been problematic primarily for two reasons. Firstly,
the use of biotype profiles to designate the Cronobacter
species was not totally robust as a few of the biotype index
strains were themselves assigned the wrong species
[16,37]. Secondly, there are seven copies of the rDNA gene
in Cronobacter and intrageneric differences can lead to
uncertain and inconsistent base calls with subsequent er-
rors in GenBank entries.
In contrast, Joseph et al. [17] used strains selected by the
seven loci multilocus sequence analysis (MLSA; 3036 bp
concatenated sequence length) as representatives across
the genus and therefore overcame the preconceived
grouping of strains based on phenotyping. These studies
led to the naming of two further Cronobacter species; C.universalis and C. condimenti [38] which as shown in Fig-
ure 1 are in the Cronobacter genus. Such recent changes
in Cronobacter taxonomy are easily adapted using the
sequence-based MLST scheme, whereas a number of cur-
rently approved methods including PCR probes require
re-evaluation. In 2013, Brady et al. [39] used MLSA with
only four loci (gyrB, rpoB, infB and atpD) for the re-
evaluation of the taxonomic status of Enterobacter helveti-
cus, E. pulveris and E. turicensis. Consequently these were
renamed C. helveticus, C. pulveris and C. zurichensis, re-
spectively. This particular re-evaluation was debatable due
to the limited number of loci used which is below the nor-
mal permitted number of five. This taxonomic change also
cause problems with the international control of Crono-
bacter spp. in powdered infant formula as many detection
methods were designed using these Enterobacter species
as negative controls [40,41]. Soon after Stephan and col-
leagues proposed the latter three species should form two
new genera named Franconibacter and Siccibacter [42].
Figure 1, using 7-loci MLSA confirms this taxonomic revi-
sion they do not cluster with the seven Cronobacter
species.
The issue of whether all Cronobacter species are of
clinical significance and need to be controlled in powdered
infant formula, and other foods has not been considered
by regulatory authorities. The lack of epidemiological evi-
dence of infection from all species cannot be substantiated
due to the frequent mis-identification of Cronobacter
strains following the routine use of phenotyping for
identification. However as shown in Table 2, only a few
C. sakazakii and C. malonaticus clonal groups have
been isolated from neonatal clinical cases. The other
species are primarily environmental commensals and
are probably of little clinical significance. Whether in-
fections have been unreported due to misidentification
is highly probable as commercially available phenotyp-
ing kits (approved in ISO and FDA detections method
protocols) still use the name E. sakazakii, and these also
identify many true Cronobacter isolates as Enterobacter
cloacae, Pantoea spp. or Erwinia spp.
Many MLST databases are now implemented using the
Bacterial Isolate Genome Sequence Database (BIGSdb)
platform [1,43]. This enables a range of MLST-like schemes
to be described and applied to whole genome sequenced
organisms, in addition to the conventional laboratory-
derived seven loci. Hence hierarchical classifications, ei-
ther pre-defined in the database or user-defined, can be
applied with progressively greater resolution as the
number of loci analysed increases. In addition to the
seven loci MLST scheme, as part of the Cronobacter site, a
specific open-access repository for all Cronobacter ge-
nomes sequenced to date has been established. This en-
ables the scalable analysis of Cronobacter genomes,
representing all recognised species, for genes of interest
a.Cronobacter genus
C. muytjensii
C. malonacus
C. sakazakii
C. universalis
C. turicensis
C. dublinensis
C. condimen
b. C. sakazakii and C. malonacus with major clonal lineages highlighted
CC7
CC4
CC1
CC8
CC45 CC13
C. sakazakii
C. malonaticus
Figure 3 7-loci Splits Network of 298 sequence types from the Cronobacter genus. (a) Analyis of the whole Cronobacter genus (b) Analysis
of C. sakazakii and C. malonaticus.
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The Cronobacter seven loci MLST scheme has recently
been extended online to include ompA and rpoB se-
quences such that these loci can add to users’ taxo-
nomic evaluations (Tax-MLST).
The separation of species is not always easy to define,
and a large number of recombination events can occur
within species, resulting in multiple plausible but only
partially consistent taxonomic trees. Consequently
NeighborNet analysis using Splitstree [44] has been applied
to the genome sequence data of Cronobacter. Whereas the
separation of C. sakazakii and C. malonaticus using 16S
rRNA gene sequencing was problematic, the two species are
clearly separated using the seven loci MLST (Figure 3 a,b).
The figure also shows the considerable genetic diversity of
C. dublinensis and C. muytjensii which has not been re-
ported before. This reflects that there is a relative large
number of sequence types for these two species. As given
in Table 1, although even combined they are only repre-
sent 9.4% of the recorded isolates, the 94 strains are com-
posed of 58 sequence types. These species are primarily
isolated from environmental sites and are of less clinical
relevance. In contrast, C. sakazakii and C. malonaticus
form distinct clusters, within which the C. sakazakii CC4
and C. malonaticus CC7 clonal complexes can be distin-
guished (Figure 3b).
Further multi-allelic analysis using genes coding for
the ribosomal proteins (rMLST, 51-loci) has been used
to integrate microbial genealogy and typing [2].
Expanding the multi-allelic analysis of Cronobacter spp.
to rMLST shows the C. sakazakii CC4 clonal lineage as
more pronounced and separate from the remaining C.
sakazakii (Figure 4). This is based on 51 of the 53Figure 4 rMLST analysis of genomes across the Cronobacter, Franconiribosomal protein sequences due to the absence of two
genes (rpsA and rpsQ) in some strains in the sample
group. This reveals the C. sakazakii ST4 clonal lineage
as defined by just seven loci is robust, and is also found
using 51 other housekeeping genes. The relevance be-
ing this sequence type is strongly associated with neo-
natal meningitis infections and has not been genotyped
to this level before.
Furthermore, genes tagged as belonging to Clusters of
Orthologous Genes (COG) can be used to generate
COG-cgMLST with 1865 loci [45]. Further expansion of
the genomic analysis using COG-defined genes of C.
sakazakii ES15 as the reference genome generated 1865
loci which could be compared across the genus or se-
lected species or strains. COG loci are identified by their
being tagged as belonging to COGs in C. sakazakii ES15
(excluding loci named in other analysis schemes). The
subsequent figure also highlights the C. sakazakii clonal
lineage CC4; Figure 5. COG-cgMLST analysis can also
be used to generate a profile of potential biochemical
traits which may be of use for differentiating strains and
species using phenotyping. This is particularly useful as
previously the choice of biochemical tests to try has
been arbitrary. In addition the scheme can be used to
study a range of physiological traits. Table 3 summarises
the presence and variation in genes associated with cell
division [46]. The core FtsLBQ cell division complex
and FtsE/FtsX ABC transporter components are found
in all Cronobacter, Franconibacter and Siccibacter ge-
nomes, whereas ftsK is only present in C. sakazakii, C.
malonaticus, C. universalis and C. turicensis. This va-
riation in cell division proteins may be linked to environ-
mental stress tolerance. Therefore the PubMLST schemebacter and Siccibacter genera.
ST31
ST12
ST4
ST16
ST125
ST1
ST3
ST40
ST8
Figure 5 COG-cgMLST analysis of Cronobacter sakazakii genomes. 7-loci MLST sequence types highlighted.
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but also readily accessible investigative profiling of strains.
Cronobacter spp. virulence traits
Cronobacter can invade human intestinal cells, replicate
in macrophages, and invade the blood brain barrier
[47,48]. The route of infection is probably through attach-
ment and invasion of the intestinal cells. Whole genome
sequencing has revealed a large number of plausible
virulence factors, though many require further laboratory
studies for confirmation [32-34]. Additionally the genomes
of 107 Cronobacter strains, including 50 C. sakazakii ST4,
are available for BLAST analysis and comparative genomic
analysis via the PubMLST database.
Ten fimbriae clusters have been identified in the ge-
nomes of Cronobacter species [34]. Many fimbriae clusters
are common to all species, though there are two interest-
ing exceptions. C. sakazakii is the only Cronobacter spe-
cies encoding for β-fimbriae, whereas the genomes of the
other species encode for curli fimbriae. This may reflect
evolution to the host ecosystem. A number of iron assimi-
lation mechanisms have been found in Cronobacter spe-
cies [49] which might enable the organism to utilize iron
from breast milk and formula. Five putative Type VI secre-
tion system (T6SS) clusters have been identified in Crono-
bacter spp. genomes. These may be involved in adherence,
cytotoxicity, host-cell invasion, growth inside macrophages
and survival within the host. It has been proposed that theouter membrane proteins ompA and ompX have roles in
Cronobacter penetrating the blood brain barrier [50]. The
mechanism(s) leading to the destruction of the brain cells
is unknown and could in part be a host response. The or-
ganism also encodes for a number of haemolysins [34].
The organism has several plasmid borne features of inter-
est including encoding for an outer membrane protease
(Cronobacter plasminogen activator) that has significant
identity to proteins belong to the Pla subfamily of omp-
tins. Members of this subfamily of proteins degrade a
number of serum proteins, including circulating com-
plement, providing protection from the complement-
dependent serum killing [51]. Having 107 genomes
representing the Cronobacter genus in a curated, open-
access database will facilitate the further analysis of
these and other virulence traits. For example, using the
BLAST facility shows the cpa gene is present in C. saka-
zakii strains (n = 72 genomes) but not C. malonaticus
(n = 14 genomes) which may partially explain the vari-
ation in host susceptibility.
Other Cronobacter characteristics of interest
Comparative genomic studies revealed that C. sakazakii
possessed the nanATKR gene cluster which encodes for
the utilization of exogenous sialic acid, and this may have
clinical significance [34,52]. The ability to utilise sialic acid
as a carbon source could be a major evolutionary host-
adaptation since the compound is found in breast milk,
Table 3 Presence of cell division genes across the Cronobacter genus and closely related genera Franconibacter and Siccibacter
Gene Function C. sakazakii
(33)a
C. malonaticus
(5)
C. universalis
(2)
C. turicensis
(2)
C. muytjensii
(2)
C. dublinensis
(5)
C. condimenti
(1)
F. helveticus
(2)
F. pulveris
(3)
S. turicensis
(3)
Candidatus S.
colletis (1)
ftsL FtsLBQ cell division
complex
33 5 2 2 2 5 1 2 3 3 1
ftsB FtsLBQ cell division
complex
33 5 2 2 2 5 1 2 3 3 1
ftsQ FtsLBQ cell division
complex
33 5 2 2 2 5 1 2 3 3 1
ftsY Signal recognition particle
protein translocation
system
32 5 2 2 2 5 0 2 3 3 1
ftsE FtsE/FtsX ABC transporter 33 5 2 2 2 5 1 2 3 3 1
ftsX1 FtsE/FtsX ABC transporter 33 5 2 2 2 5 1 2 3 3 1
ftsX2 FtsE/FtsX ABC transporter 28 5 2 2 1 4 1 2 3 3 1
ftsI Penicillin-binding
protein 3
33 5 2 2 2 5 1 2 3 3 1
ftsW Lipid II flippase 33 5 2 2 2 5 1 2 3 3 1
ftsA Essential cell division
protein
33 5 2 2 2 5 1 2 3 3 1
ftsZ Essential cell division
protein
33 5 2 2 2 5 1 2 3 3 1
zipA Essential cell division
protein
33 5 2 2 2 5 1 0 0 0 0
ftsN Uncertain 33 5 2 2 2 5 1 0 3 0 0
ftsK DNA translocase 29 5 1 2 0 0 0 0 0 0 0
aNumber of genomes analysed.
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http://www.biomedcentral.com/1471-2164/15/1121mucin and gangliosides. Sialic acid is also an ingredient in
powdered infant formula due to its association with brain
development. Laboratory studies designed to confirm the
sialic acid utilization was active in C. sakazakii and also
showed the species was able to grow on the ganglioside
GM1 as a sole carbon source [52]. In contrast, unlike
other Cronobacter species, C. sakazakii is unable to use
malonic acid. Genomic analysis shows the malonate de-
carboxylase genes are next to an auxin efflux carrier which
may function in malonate uptake. Malonic acid is an or-
ganic acid which is found in plant tissues and reflects the
plant-association of the Cronobacter genus. The adapta-
tion of C. sakazakii to a new ecosystem, with the subse-
quent loss of malonate utilization and gain in sialic acid
utilization might contribute to this clinical significance.
Cronobacter genomes also show the presence of a number
of heavy metal resistance traits (copper, silver, zinc, tellur-
ite) and capsule formation which might enable it to resist
disinfectants in food production environments.
Hence the Cronobacter PubMLST database enabled re-
searchers to study the detailed ecology, taxonomy and vi-
rulence of the organism. A timeline of key Cronobacter
events are given in Additional file 1: Box 3, and list the vari-
ous contributions of the Cronobacter PubMLST database.
Conclusions
This paper demonstrates the application of NGS to Cro-
nobacter, an emergent bacterial pathogen which had
been poorly defined as a single species Enterobacter
sakazakii. The advantages of a centralised multilocus se-
quence typing (MLST) database (i.e., http://pubmlst.org/
cronobacter/) for genotyping the organism and recognis-
ing clinically relevant clonal lineages has been demon-
strated using just seven loci. These lineages have been
confirmed by 51-loci rMLST and even whole genome al-
lelic profiling to the clone level. In addition, the three
FAO-WHO key requests have been addressed by im-
plementing this database using the BIGSdb platform, en-
abling the inclusion of 107 complete genomes within the
1007 recorded isolates. This database has also enabled
the retrospective analysis of historic cases and outbreaks
following re-identification of those strains and hence
minimized the loss in information following taxonomic
re-evaluations.
The multilocus sequence typing (MLST) and analysis
(MLSA) approaches have:
a. Revealed the diversity of the genus
b. Contributed to the recognition of new species
c. Shown the relatedness of the species,
d. Shown the evolutionary decent of the genus
e. Revealed the majority of neonatal meningitis cases
are being attributable to one clonal lineage, C.
sakazakii ST4 (CC4)f. Form the basis for future research regarding strain
selection for investigating Cronobacter virulence and
environmental fitness.
The Cronobacter PubMLST database offers a central,
open access, reliable sequence-based repository. It has
the capacity to create new analysis schemes ‘on the fly’
and integrate metadata (source, geographic distribution,
clinical presentation). The database is able to adapt to
changes in taxonomy and offers expandable analysis
through BIGSdb implementation.
By producing a phylogenetic network for increasingly
large fractions of the genome, rMLST and COG-
cgMLST facilitate the identification of sequence types
and species, while illustrating the ambiguities inherent
in phylogenetic reconstruction across a genus. The ap-
plication of Next Generation Sequencing has not only
met the objectives of the 2004 FAO-WHO tasks, but
continues to exceed them as the number of sequenced
genomes has progressed.
Methods
Source DNA sequences
DNA sequences collated at http://pubmlst.org/cronobac-
ter/ were investigated and Table 1 gives a summary of
these strains. In silico analyses were carried out using
options on the Cronobacter PubMLST portal accessible
at: http://pubmlst.org/perl/bigsdb/bigsdb.pl?db=pubmlst_
cronobacter_isolates.
Seven loci MLST analysis
Concatenated sequences of seven loci from 298 sequence
types were downloaded in FASTA format using the Ex-
port/Sequences option. These sequences were aligned in
MEGA version 6.05 using the ClustalW algorithm. The
final alignment spanned 3036 bp and was analysed using
the default pipeline in SplitsTree4 (UncorrectedP to calcu-
late distances and NeighborNet to build the network).
rMLST analysis
A distance matrix for 107 Cronobacter genomes with
available whole-genome sequences (and representing the
whole genus [2]) was calculated with the Analysis/Genome
Comparator option using default settings (with tagged allele
designations used if available and completely excluding
truncated loci). The matrix was exported in nexus format
and analysed using the default pipeline in SplitsTree 4
(as above).
COG-cgMLST scheme set-up and analysis
COG-cgMLST uses genes annotated as belonging to
Clusters of Orthologous Groups [45] to define 1865 loci.
The locus list, including reference sequences from Crono-
bacter sakazakii ES15, was assembled using an in-house
Forsythe et al. BMC Genomics 2014, 15:1121 Page 13 of 14
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CP003312.1 in which the < note > field included a COG
identifier. Sequences from these tagged loci were ex-
tracted and uploaded to the Cronobacter sequence defi-
nitions database excluding loci already named therein.
Further scripts were used to establish COG-cgMLST
locus scheme initially containing 1866 loci. The scheme
was subsequently edited to exclude the locus ppsA
(identical to pps in MLST) yielding 1865 loci.
With the scheme established, analysis was carried out
as above with the use of the Analysis/Genome Compara-
tor option and the default pipeline in SplitsTree4 (as
above). Note that the Genome Comparator option with
COG-cgMLST will analyse samples directly against the
reference-defined loci and not with reference to COG
IDs in query genomes.Additional file
Additional file 1: Box 1. FAO-WHO executive summary (2004); see
footnote. Box 2. Box 3. Summary timeline of Cronobacter recognition,
control and molecular profiling [53].Abbreviations
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